Nitrobenzene

Nitrobenzene

SCHEMBL8084891

CS(N)(=O)=O.O=[N+]([O-])c1ccccc1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.70
LMNA P02545 2/20 0.70
CA2 P00918 8/20 0.57
CA1 P00915 6/20 0.57
CA9 Q16790 6/20 0.57
CA12 O43570 4/20 0.57
CA5A P35218 4/20 0.57
CA14 Q9ULX7 3/20 0.57
CA3 P07451 2/20 0.57
CA4 P22748 2/20 0.57
CA6 P23280 2/20 0.57
CA7 P43166 2/20 0.57
CA13 Q8N1Q1 2/20 0.57
CA5B Q9Y2D0 2/20 0.57
L3MBTL1 Q9Y468 2/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
CRHBP P24387 1/20 0.48
ATM Q13315 1/20 0.48
CRHR2 Q13324 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitrobenzene SCHEMBL3818354 0.91 ALDH1A1 (0.76) ALDH1A1LMNACA2CA1CA9
Nitrobenzene SCHEMBL28275059 0.91 LMNA (0.76) ALDH1A1LMNACA2CA1CA9
Nitrobenzene SCHEMBL27560682 0.87 ALDH1A1 (0.70) ALDH1A1LMNACA2CA1CA9
Nitrobenzene SCHEMBL28261425 0.87 ALDH1A1 (0.70) ALDH1A1LMNACA2CA1CA9
Nitrobenzene SCHEMBL31005945 0.87 ALDH1A1 (0.70) ALDH1A1LMNACA2CA1CA9
Nitrobenzene SCHEMBL6572610 0.87 ALDH1A1 (0.70) ALDH1A1LMNACA2CA1CA9
Nitrobenzene SCHEMBL11742643 0.86 ALDH1A1 (0.84) ALDH1A1LMNACA2CA1CA9
Nitrobenzene SCHEMBL17873899 0.86 ALDH1A1 (0.61) ALDH1A1LMNACA2CA1CA9
Nitrobenzene SCHEMBL28046944 0.84 ALDH1A1 (0.80) ALDH1A1LMNACA2CA1CA9
Nitrobenzene SCHEMBL28089388 0.84 ALDH1A1 (0.89) ALDH1A1LMNACA2CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110143999-A Have cytotoxicity and antimitotic compound and its application method 酵活有限公司 2019-08-20 CN disclosed
CN-105358174-B Cytotoxic and antimitotic compounds and methods of use thereof 酵活有限公司 2019-03-15 CN disclosed
CN-105358174-A Cytotoxic and antimitotic compounds and methods of use thereof CT FOR DRUG RES AND DEV 2016-02-24 CN disclosed
CN-102432519-B Preparation method of 3-(2-aminoethyl)-N-methyl-1H-indole-5-methanesulfonamide SHANDONG XINHUA PHARMACEUTICAL 2013-12-11 CN disclosed
CN-102432519-A Preparation method of 3- (2-aminoethyl) -N-methyl-1H-indole-5-methanesulfonamide SHANDONG XINHUA PHARMACEUTICAL 2012-05-02 CN disclosed
US-6025374-A Azetidine, pyrrolidine and piperidine derivatives as 5HT1 receptor agonists MERCK SHARP & DOHME, LTD. (GB) 2000-02-15 US disclosed
EP-0796258-A1 AZETIDINE, PYRROLIDINE AND PIPERIDINE DERIVATIVES AS 5HT1 RECEPTOR AGONISTS MERCK SHARP & DOHME LTD. (GB) 1997-09-24 EP disclosed
WO-1996017842-A1 AZETIDINE, PYRROLIDINE AND PIPERIDINE DERIVATIVES AS 5HT1 RECEPTOR AGONISTS MERCK SHARP & DOHME LIMITED (GB) 1996-06-13 WO disclosed